Contributions of vasoactive substances in cases of chronic arteriosclerotic occlusion in the lower extremities.
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D009531:Niceritrol / Q000494:pharmacology*; D009538:Nicotine / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000097:blood; D012701:Serotonin / Q000097:blood; D014655:Vascular Resistance / Q000187:drug effects
D008055:Lipids; D009539:Nicotinic Acids; D012701:Serotonin; D009538:Nicotine; D009531:Niceritrol; D009638:Norepinephrine